Search Results
Search for other papers by Xiuzhen Hou in
Google Scholar
PubMed
Search for other papers by Junfeng Zhang in
Google Scholar
PubMed
Search for other papers by Hehong Ma in
Google Scholar
PubMed
Search for other papers by Ming Li in
Google Scholar
PubMed
Search for other papers by Pei Wang in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) is primarily resulted from insulin resistance and glucose intolerance during pregnancy, affecting 7% of pregnant women globally ( 1 , 2 ). GDM causes higher risks of diabetes, obesity and
Search for other papers by Zhiwei Zhang in
Google Scholar
PubMed
Search for other papers by Hui Zhao in
Google Scholar
PubMed
Search for other papers by Aixia Wang in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) manifests as various degrees of hyperglycemia during pregnancy. GDM has a high incidence rate and is by far one of the leading causes of neonatal and maternal mortality ( 1 ). The etiology of
Search for other papers by Yusen Liu in
Google Scholar
PubMed
Search for other papers by Ruiwen Chi in
Google Scholar
PubMed
Search for other papers by Yujie Jiang in
Google Scholar
PubMed
Search for other papers by Bicheng Chen in
Google Scholar
PubMed
Search for other papers by Youli Chen in
Google Scholar
PubMed
Search for other papers by Zengrui Chen in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM), the most common medical disorder in pregnancy, is defined as glucose intolerance resulting in hyperglycemia that begins or is first diagnosed during pregnancy ( 1 ). GDM is associated with
Search for other papers by Chenyu Jiang in
Google Scholar
PubMed
Search for other papers by Mi Zhou in
Google Scholar
PubMed
Search for other papers by Huai Bai in
Google Scholar
PubMed
Search for other papers by Meng Chen in
Google Scholar
PubMed
Search for other papers by Chunyi Yang in
Google Scholar
PubMed
Search for other papers by Kaifeng Hu in
Google Scholar
PubMed
Search for other papers by Yujie Wu in
Google Scholar
PubMed
Search for other papers by Qingqing Liu in
Google Scholar
PubMed
Search for other papers by Yangyu Zhao in
Google Scholar
PubMed
Search for other papers by Xinghui Liu in
Google Scholar
PubMed
Search for other papers by Ping Fan in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases in obstetrics, characterized by carbohydrate intolerance that develops during pregnancy ( 1 ). Along with the increasing prevalence of obesity
Search for other papers by Chenghao Piao in
Google Scholar
PubMed
Search for other papers by Xiaojie Wang in
Google Scholar
PubMed
Search for other papers by Shiqiao Peng in
Google Scholar
PubMed
Search for other papers by Xinyu Guo in
Google Scholar
PubMed
Search for other papers by Hui Zhao in
Google Scholar
PubMed
Search for other papers by Li He in
Google Scholar
PubMed
Search for other papers by Yan Zeng in
Google Scholar
PubMed
Search for other papers by Fan Zhang in
Google Scholar
PubMed
Search for other papers by Kewen Zhu in
Google Scholar
PubMed
Search for other papers by Yiwei Wang in
Google Scholar
PubMed
Introduction Insulin sensitivity during pregnancy is reduced with the advancement of gestation. Thus, the demand for insulin is elevated to maintain the common blood sugar ( 1 ). Gestational diabetes mellitus (GDM) is characterized by glucose
Search for other papers by Panisa Hantrakun in
Google Scholar
PubMed
Search for other papers by Rattanaporn Sekararithi in
Google Scholar
PubMed
Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed
Search for other papers by Sirinart Kumfu in
Google Scholar
PubMed
Search for other papers by Chatree Chai-adisaksopha in
Google Scholar
PubMed
Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed
Search for other papers by Theera Tongsong in
Google Scholar
PubMed
Search for other papers by Phudit Jatavan in
Google Scholar
PubMed
Gestational diabetes mellitus (GDM), one of the most common complications in pregnancy, is defined as glucose intolerance of variable severity with onset or first recognition during pregnancy ( 1 ). GDM usually disappears shortly after birth but up to 50% will
Search for other papers by Yao Su in
Google Scholar
PubMed
Search for other papers by Li Chen in
Google Scholar
PubMed
Search for other papers by Dong-Yao Zhang in
Google Scholar
PubMed
Search for other papers by Xu-Pei Gan in
Google Scholar
PubMed
Search for other papers by Yan-Nan Cao in
Google Scholar
PubMed
Search for other papers by De-Cui Cheng in
Google Scholar
PubMed
Search for other papers by Wen-Yu Liu in
Google Scholar
PubMed
Search for other papers by Fei-Fei Li in
Google Scholar
PubMed
Search for other papers by Xian-Ming Xu in
Google Scholar
PubMed
Search for other papers by Hong-Kun Wang in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) is one of the most common complications during pregnancy, and the incidence rate is increasing every year and is currently approximately 17.5% in China ( 1 ). GDM is harmful to the long- and
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Liliana Fonseca in
Google Scholar
PubMed
Search for other papers by Maria Teresa Pereira in
Google Scholar
PubMed
Search for other papers by Joana Vilaverde in
Google Scholar
PubMed
Search for other papers by Clara Pinto in
Google Scholar
PubMed
Search for other papers by Fernando Pichel in
Google Scholar
PubMed
Search for other papers by Maria do Céu Almeida in
Google Scholar
PubMed
Search for other papers by Jorge Dores in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus(GDM) is defined as a subtype of hyperglycemia first detected during pregnancy and accounts for 90% of all diabetes diagnoses in pregnant women ( 1 , 2 ). This represents a worrying gestational
Search for other papers by Hathairat Rueangdetnarong in
Google Scholar
PubMed
Search for other papers by Rattanaporn Sekararithi in
Google Scholar
PubMed
Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed
Search for other papers by Sirinart Kumfu in
Google Scholar
PubMed
Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed
Search for other papers by Theera Tongsong in
Google Scholar
PubMed
Search for other papers by Phudit Jatavan in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) is the most common metabolic disease in pregnancy, characterized by abnormal blood sugar levels, leading to several maternal and neonatal adverse outcomes ( 1 ). Currently, the prevalence of GDM
Search for other papers by Hana Vítková in
Google Scholar
PubMed
Search for other papers by Kateřina Anderlová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Radovan Bílek in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Felix Votava in
Google Scholar
PubMed
Search for other papers by Tomáš Brutvan in
Google Scholar
PubMed
Search for other papers by Adéla Krausová in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Eliška Potluková in
Google Scholar
PubMed
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
Introduction: Maternal urinary iodine concentration (UIC) and blood neonatal thyroid stimulating hormone (TSH) concentration reflect iodine status in pregnancy. As dietary measures in gestational diabetes mellitus (GDM) could affect iodine intake, our study aimed to investigate iodine supply in women with GDM compared to healthy pregnant women and to evaluate its relationship to thyroid function.
Methods: UIC and serum TSH, free thyroxine (FT4) and autoantibodies against thyroid peroxidase (TPOAb) were analysed in 195 women with GDM and 88 healthy pregnant women in the 2nd trimester. Subsequently, neonatal TSH concentrations measured 72 hours after delivery in a subgroup of 154 newborns (115 of mothers with GDM and 39 controls) from the national register were analysed.
Results: Optimal iodine intake was found only in nine women with GDM (4.6%) and 33 healthy pregnant women (37.5%) (P<0.001). Most pregnant women with GDM (88.7%) as compared to one half of controls (50%) had iodine deficiency (P<0.001). Also, hypothyroxinaemia was more prevalent in GDM compared to controls (12.3% vs 3.4%, P = 0.032). Consistently, neonatal TSH >5.0 mIU/L indicating iodine deficiency was found in 6 (5.2%) newborns of women with GDM as compared to none in controls. In the multiple logistic and linear regression models in women with GDM, hypothyroxinaemia was associated with preterm births, and a negative association of serum FT4 and HbA1c was found.
Conclusion: Iodine deficiency in pregnancy was more prevalent among women with GDM compared to healthy pregnant controls. Hypothyroxinaemia was associated with preterm births in women with GDM.